CanCertainty is a partner of the Cancer Clinician Advocacy Forum (CCAF).

CCAF is funded through a partnership with the CanCertainty Coalition – the united voice of more than 35 Canadian patient groups, cancer health charities and caregiver organizations working with oncologists and cancer care professionals to improve the affordability and accessibility of cancer treatment. CanCertainty’s funding is supported by in-kind collaboration and support from more than 35 partner organizations and corporate donations, and funding from Kidney Cancer Canada. Corporate supporters on the CCAF project include unrestricted financial contributions from Merck Canada, Eli Lilly Canada, Novartis Canada, AbbVie Canada, Gilead Canada, AstraZeneca Canada, Pfizer Canada and J&J. CCAF and its partner CanCertainty only accept corporate support under the terms of the Corporate transparency and code of conduct of Kidney Cancer Canada – Cancer du Rein Canada, which can be found here.